Ranran Dai

620 total citations
34 papers, 417 citations indexed

About

Ranran Dai is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Ranran Dai has authored 34 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Ranran Dai's work include Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers), Asthma and respiratory diseases (6 papers) and Respiratory Support and Mechanisms (4 papers). Ranran Dai is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers), Asthma and respiratory diseases (6 papers) and Respiratory Support and Mechanisms (4 papers). Ranran Dai collaborates with scholars based in China, United States and South Korea. Ranran Dai's co-authors include Guochao Shi, Yingmeng Ni, Yahui Liu, Yaling Pan, Lei Fan, Wei Du, Zhongpai Gao, Ping Wang, Chunrong Huang and Yong Lü and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Frontiers in Immunology.

In The Last Decade

Ranran Dai

32 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ranran Dai China 12 157 140 74 57 57 34 417
Annette Dent Australia 10 134 0.9× 199 1.4× 73 1.0× 198 3.5× 40 0.7× 14 644
Xiangyu Chen China 10 70 0.4× 89 0.6× 16 0.2× 22 0.4× 40 0.7× 34 443
Yujia Ma China 13 171 1.1× 65 0.5× 13 0.2× 82 1.4× 112 2.0× 47 576
Gangling Tong China 10 130 0.8× 65 0.5× 38 0.5× 87 1.5× 80 1.4× 29 458
Yuan Cheng China 10 90 0.6× 96 0.7× 25 0.3× 24 0.4× 42 0.7× 49 341
Mariaenrica Tinè Italy 13 233 1.5× 299 2.1× 99 1.3× 105 1.8× 113 2.0× 45 576
Aiping Ma China 11 110 0.7× 148 1.1× 63 0.9× 36 0.6× 26 0.5× 25 394
Goh Tanaka Japan 11 104 0.7× 149 1.1× 34 0.5× 35 0.6× 38 0.7× 43 376

Countries citing papers authored by Ranran Dai

Since Specialization
Citations

This map shows the geographic impact of Ranran Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranran Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranran Dai more than expected).

Fields of papers citing papers by Ranran Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranran Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranran Dai. The network helps show where Ranran Dai may publish in the future.

Co-authorship network of co-authors of Ranran Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Ranran Dai. A scholar is included among the top collaborators of Ranran Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranran Dai. Ranran Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Jiaojiao, et al.. (2024). A novel nanoplatform-based circCSNK1G3 affects CBX7 protein and promotes glioma cell growth. International Journal of Biological Macromolecules. 276(Pt 2). 134025–134025. 1 indexed citations
2.
3.
Zhang, Bowen, Zhen Zhang, Feizhen Wu, et al.. (2024). SMC3 contributes to heart development by regulating super-enhancer associated genes. Experimental & Molecular Medicine. 56(8). 1826–1842. 3 indexed citations
4.
Zhu, Yongchang, et al.. (2023). Integration of ATAC-seq and RNA-seq identifies MX1-mediated AP-1 transcriptional regulation as a therapeutic target for Down syndrome. Biological Research. 56(1). 67–67. 5 indexed citations
5.
Ni, Yingmeng, Juan Du, Ping Wang, et al.. (2023). Effective omalizumab treatment influenced eosinophil function in severe allergic asthmatics. Journal of Thoracic Disease. 15(6). 3115–3125. 1 indexed citations
6.
Dai, Ranran, et al.. (2023). Three-way contact analysis characterizes the higher order organization of the Tcra locus. Nucleic Acids Research. 51(17). 8987–9000.
7.
Xu, Hao, Zhiyao Bao, Ranran Dai, et al.. (2023). A pilot study on Paxlovid therapy for hemodialysis patients with severe acute respiratory syndrome coronavirus 2 infections. Frontiers of Medicine. 18(1). 169–179. 1 indexed citations
8.
Chen, Yanhong, Ranran Dai, Zhaoqiang Li, et al.. (2022). Chromatin organizer SATB1 controls the cell identity of CD4+ CD8+ double-positive thymocytes by regulating the activity of super-enhancers. Nature Communications. 13(1). 5554–5554. 22 indexed citations
9.
Peng, Bo, Meng Zhang, Guochao Shi, et al.. (2022). Role of IL-25 on Eosinophils in the Initiation of Th2 Responses in Allergic Asthma. Frontiers in Immunology. 13. 842500–842500. 14 indexed citations
10.
Zeng, Ran, Lifeng Luo, Zhiyao Bao, et al.. (2021). EGFR/BRAF/MEK co-inhibition for EGFR-mutated lung adenocarcinoma patients with an acquired BRAFV600E mutation: a case report and review of literature. Cancer Drug Resistance. 4(4). 1019–1027. 6 indexed citations
11.
Yang, Fan, et al.. (2021). METTL3-Mediated N6-Methyladenosine Modification Is Involved in the Dysregulation of NRIP1 Expression in Down Syndrome. Frontiers in Cell and Developmental Biology. 9. 621374–621374. 8 indexed citations
12.
Dai, Ranran, Qingping Jiang, You Zhou, et al.. (2021). Lnc-STYK1-2 regulates bladder cancer cell proliferation, migration, and invasion by targeting miR-146b-5p expression and AKT/STAT3/NF-kB signaling. Cancer Cell International. 21(1). 408–408. 16 indexed citations
13.
Yang, Yiting, Ranran Dai, Wei Xue, et al.. (2021). Phase separation of Epstein-Barr virus EBNA2 protein reorganizes chromatin topology for epigenetic regulation. Communications Biology. 4(1). 967–967. 25 indexed citations
14.
Hu, Menghan, Zhongpai Gao, Lei Fan, et al.. (2020). Detection of Respiratory Infections Using RGB-Infrared Sensors on Portable Device. IEEE Sensors Journal. 20(22). 13674–13681. 50 indexed citations
15.
Huang, Chunrong, Wei Du, Yahui Liu, et al.. (2020). Fungal and bacterial microbiome dysbiosis and imbalance of trans-kingdom network in asthma. Clinical and Translational Allergy. 10(1). 42–42. 45 indexed citations
16.
Dai, Ranran, et al.. (2018). Intratracheal administration of adipose derived mesenchymal stem cells alleviates chronic asthma in a mouse model. BMC Pulmonary Medicine. 18(1). 131–131. 30 indexed citations
17.
Yang, Dexiang, Ranran Dai, Qi Zhang, & Ping Fang. (2017). Apatinib for heavily treated patients with non-small cell lung cancer: Report of a case series and literature review. Saudi Journal of Biological Sciences. 25(5). 888–894. 6 indexed citations
18.
Seiffert, Joanna, Bey Fen Leo, Jie Zhu, et al.. (2016). Pulmonary effects of inhalation of spark-generated silver nanoparticles in Brown-Norway and Sprague–Dawley rats. Respiratory Research. 17(1). 85–85. 43 indexed citations
19.
Zhang, Qiurui, et al.. (2015). Suppressor of cytokine signaling 1-modulated metalloproteinases and tissue inhibitor of metalloproteinase in pulmonary fibrosis. Molecular Medicine Reports. 12(3). 3855–3861. 16 indexed citations
20.
Gong, Yi, Guochao Shi, Wan Huan-ying, et al.. (2013). Association between the interleukin-13 gene and development of chronic obstructive pulmonary disease in southern Chinese Han population: a case-control study. Chinese Medical Journal. 126(23). 4403–4408. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026